University of Basel-ko ikertzaileekin lankidetzan egindako argitalpenak (70)

2023

  1. Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry

    Multiple Sclerosis Journal, Vol. 29, Núm. 2, pp. 221-235

  2. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  3. Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial

    Journal of neurology, neurosurgery, and psychiatry, Vol. 94, Núm. 12, pp. 1004-1011

  4. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  5. Impact of long-term exposure to ambient ozone on lung function over a course of 20 years (The ECRHS study): a prospective cohort study in adults

    The Lancet Regional Health - Europe, Vol. 34

  6. Long-term effect of asthma on the development of obesity among adults: an international cohort study, ECRHS

    Thorax, Vol. 78, Núm. 2, pp. 128-135

  7. Residential greenspace and lung function decline over 20 years in a prospective cohort: The ECRHS study

    Environment International, Vol. 178

  8. The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

    Brain : a journal of neurology, Vol. 146, Núm. 11, pp. 4633-4644

  9. Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis

    European Journal of Neurology, Vol. 30, Núm. 4, pp. 1014-1024